Pharmacological treatment of ambulatory schizophrenic patients in Belgium
- PMID: 16734909
- PMCID: PMC1481604
- DOI: 10.1186/1745-0179-2-11
Pharmacological treatment of ambulatory schizophrenic patients in Belgium
Abstract
Background: the objective of this study was twofold:1) Describe the use of antipsychotic treatments in ambulatory patients suffering from schizophrenia in Belgium.2) Evaluate to which extend antipsychotic treatment prescribing patterns are in accordance with published treatment guidelines.
Method: A cross-sectional survey was carried out in 16 Belgian hospitals selected from a sample of 67 hospitals. The hospitals were equally distributed between the north and south part of the country and were representative of Belgian practice. During 2 months, participating psychiatrists were asked to record the medication use as well as demographic parameters of all consecutive ambulatory patients seen at their consultation or attending a day-hospital. Data concerning 1000 ambulatory patients with schizophrenia or schizoaffective disorder were collected.
Results: In Belgium, the use of atypical antipsychotics is frequent (69%) in ambulatory patients with schizophrenia. In the overall sample, 73% receive only one antipsychotic drug. The majority of patients are treated with drugs of only one antipsychotic drug group, either first- typical (29.8%) or second-generation, atypical antipsychotics (53.2%). 15.8% of patients combine different types of antipsychotics. Antipsychotic dosing is adequate for the majority of patients but about one fifth receives a higher than recommended dose as per package inserts. Polypharmacy remains within reasonable limits. The use of concomitant medication varies according the antipsychotic treatment: patients who take second-generation antipsychotics only, receive the least additional drugs.
Conclusion: Atypical antipsychotics appear to be the first line treatment for schizophrenic psychosis. Psychiatrists working with ambulatory patients are well aware of treatment guidelines and follow them quite adequately.
Figures





Similar articles
-
Pharmacological treatment of hospitalised schizophrenic patients in Belgium.Int J Psychiatry Clin Pract. 2006;10(4):285-90. doi: 10.1080/13651500600811206. Int J Psychiatry Clin Pract. 2006. PMID: 24941148
-
Using antipsychotic agents in older patients.J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.
-
[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. Encephale. 2009. PMID: 19393381 French.
-
The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.J Clin Psychiatry. 2003;64 Suppl 12:5-19. J Clin Psychiatry. 2003. PMID: 14640142
-
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Hum Psychopharmacol. 2011. PMID: 23055416 Review.
Cited by
-
Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting.Int Clin Psychopharmacol. 2017 May;32(3):161-168. doi: 10.1097/YIC.0000000000000165. Int Clin Psychopharmacol. 2017. PMID: 28181959 Free PMC article.
-
National database study on the use of long-acting antipsychotic injections and hospital readmission proportions in patients with schizophrenia in Japan.Psychiatry Clin Neurosci. 2020 Mar;74(3):211-217. doi: 10.1111/pcn.12970. Epub 2020 Feb 3. Psychiatry Clin Neurosci. 2020. Retraction in: Psychiatry Clin Neurosci. 2020 Aug;74(8):447. doi: 10.1111/pcn.13086. PMID: 31875333 Free PMC article. Retracted.
-
Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.Schizophr Res. 2012 Jun;138(1):18-28. doi: 10.1016/j.schres.2012.03.018. Epub 2012 Apr 24. Schizophr Res. 2012. PMID: 22534420 Free PMC article.
-
A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.PLoS One. 2015 Oct 1;10(10):e0139403. doi: 10.1371/journal.pone.0139403. eCollection 2015. PLoS One. 2015. PMID: 26427051 Free PMC article.
-
Safety and tolerability of antipsychotic polypharmacy.Expert Opin Drug Saf. 2012 Jul;11(4):527-42. doi: 10.1517/14740338.2012.683523. Epub 2012 May 8. Expert Opin Drug Saf. 2012. PMID: 22563628 Free PMC article.
References
-
- Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry. 1988;45:79–91. - PubMed
-
- Kulkarni J, Power P. In: The recognition and management of early psychosis. McGorry P, Jackson H, editor. Cambridge: University Press; 1999. Initial treatment of first-episode psychosis; pp. 184–205.
-
- NICE (National Institute for Clinical Excellence) Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. London: NICE; 2002.
-
- De Hert M, Peuskens J. Schizofrene psychose. Welzijnsgids – Gezondheidszorg, Geestelijke Gezondheid. 2002. pp. 161–186.
LinkOut - more resources
Full Text Sources